Researchers develop new score to predict the risk of liver cancer
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed…
Preoperative combination treatment shows promise for some patients with pancreatic cancer
A new UCLA investigator-initiated study sponsored by the UCLA Health Jonsson Comprehensive Cancer Center has found that adding immunotherapy to…
Man Takes Sleep Meds Before Bed—What He Wakes Up to Unlocks ‘New Fear’
A doctor shared the scary story of what happened when he took his sleep medicine before bed, and…
Study reveals a new facet of how pancreatic cancer cells regulate autophagy
A feature of pancreatic cancer cells’ surroundings determines whether they grow fast or become resistant to chemotherapy, a…
Chronic inflammation shapes cancer progression and immunotherapy response
Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs,…
Osteoprotegerin links bone metabolism to cardiovascular disease
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Osteoprotegerin (OPG), a glycoprotein in the tumor…
Finding cancer cells in a cocktail of complex tissues – Sciworthy
Cancer disrupts several layers of biological blueprints, including the order of DNA sequences and chemical tags on DNA…
Transcription factor HOXD13 drives melanoma growth and immune evasion
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’…
New nanoparticles enable the removal of melanoma tumors with low-power laser
Researchers at Oregon State University have developed and tested in a mouse model a new type of nanoparticle…
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…
New genetic model reveals role of keratin 8 in colorectal cancer development
Researchers at Ã…bo Akademi University have identified a new molecular change in patients with colorectal cancer and developed…
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…